The experimental results showed that the knockdown of PHKG2 significantly improved the radioresistance in NSCLC, as demonstrated by the significantly higher tumor growth rate and larger experimental endpoint tumor size under radiotherapy treatment (Fig. 6A). This evidence concerns the gene PHKG2 and non-small cell lung carcinoma.